Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 436725, 7 pages
http://dx.doi.org/10.1155/2014/436725
Research Article

Pretransplant HbA1c Is a Useful Predictor for the Development of New-Onset Diabetes in Renal Transplant Recipients Receiving No or Low-Dose Erythropoietin

1Department of Surgery, Sendai Shakaihoken Hospital, Sendai 980-8574, Japan
2Division of Transplantation, Reconstruction and Endoscopic Surgery, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan

Received 30 March 2014; Revised 23 September 2014; Accepted 1 October 2014; Published 16 October 2014

Academic Editor: Muhammad Shahab

Copyright © 2014 Kazuaki Tokodai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hjelmesæth, A. Hartmann, T. Leivestad et al., “The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events,” Kidney International, vol. 69, no. 3, pp. 588–595, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. B. L. Kasiske, “Epidemiology of cardiovascular disease after renal transplantation,” Transplantation, vol. 72, no. 6, pp. S5–S8, 2001. View at Google Scholar · View at Scopus
  3. B. L. Kasiske, J. J. Snyder, D. Gilbertson, and A. J. Matas, “Diabetes mellitus after kidney transplantation in the United States,” The American Journal of Transplantation, vol. 3, no. 2, pp. 178–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. F. G. Cosio, T. E. Pesavento, S. Kim, K. Osei, M. Henry, and R. M. Ferguson, “Patient survival after renal transplantation: IV. Impact of post-transplant diabetes,” Kidney International, vol. 62, no. 4, pp. 1440–1446, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. V. K. Revanur, A. G. Jardine, D. B. Kingsmore, B. C. Jaques, D. H. Hamilton, and R. M. Jindal, “Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation,” Clinical Transplantation, vol. 15, no. 2, pp. 89–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Tuomilehto, J. Lindström, J. G. Eriksson et al., “Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance,” The New England Journal of Medicine, vol. 344, no. 18, pp. 1343–1350, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin,” The New England Journal of Medicine, vol. 346, no. 6, pp. 393–403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Tokodai, N. Amada, H. Kikuchi, I. Haga, T. Takayama, and A. Nakamura, “Posttransplant increase of body mass index is associated with new-onset diabetes mellitus after kidney transplantation,” Tohoku Journal of Experimental Medicine, vol. 229, no. 3, pp. 227–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Tokodai, N. Amada, H. Kikuchi, I. Haga, T. Takayama, and A. Nakamura, “Body fat percentage as a marker of new-onset diabetes mellitus after kidney transplantation,” Transplantation Proceedings, vol. 45, no. 4, pp. 1544–1547, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Unwin, J. Shaw, P. Zimmet, and K. G. M. M. Alberti, “Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention,” Diabetic Medicine, vol. 19, no. 9, pp. 708–723, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. J. Joshipura, M. O. Andriankaja, F. B. Hu, and C. S. Ritchie, “Relative utility of 1-h Oral Glucose Tolerance Test as a measure of abnormal glucose homeostasis,” Diabetes Research and Clinical Practice, vol. 93, no. 2, pp. 268–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Tokodai, N. Amada, I. Haga, T. Takayama, and A. Nakamura, “The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 298–303, 2014. View at Publisher · View at Google Scholar
  13. “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010.
  14. The International Expert Committee, “International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes,” Diabetes Care, vol. 32, no. 7, pp. 1327–1334, 2009. View at Publisher · View at Google Scholar
  15. C. Droumaguet, B. Balkau, D. Simon et al., “Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR),” Diabetes Care, vol. 29, no. 7, pp. 1619–1625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Inoue, M. Matsumoto, and K. Akimoto, “Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes,” Diabetic Medicine, vol. 25, no. 10, pp. 1157–1163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Hoban, B. Gielda, M. Temkit et al., “Utility of HbA1c in the detection of subclinical post renal transplant diabetes,” Transplantation, vol. 81, no. 3, pp. 379–383, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Shabir, S. Jham, L. Harper, S. Ball, R. Borrows, and A. Sharif, “Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation,” Transplant International, vol. 26, no. 3, pp. 315–321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. T. G. Valderhaug, T. Jenssen, A. Hartmann et al., “Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation,” Transplantation, vol. 88, no. 3, pp. 429–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Ng, P. E. Jennings, P. Laboi, and V. Jayagopal, “Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c),” Diabetic Medicine, vol. 25, no. 2, pp. 239–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Ng, M. Cooke, S. Bhandari, S. L. Atkin, and E. S. Kilpatrick, “The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease,” Diabetes Care, vol. 33, no. 11, pp. 2310–2313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Nakao, H. Matsumoto, T. Okada et al., “Influence of erythropoietin treatment on hemoglobin A(1c) levels in patients with chronic renal failure on hemodialysis,” Internal Medicine, vol. 37, no. 10, pp. 826–830, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Tatar, F. Kircelli, M. S. Demirci et al., “Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation,” International Urology and Nephrology, vol. 45, no. 1, pp. 251–258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kashiwagi, M. Kasuga, E. Araki et al., “International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values,” Journal of Diabetes Investigation, vol. 3, no. 1, pp. 39–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 27, supplement 1, pp. S5–S10, 2004. View at Publisher · View at Google Scholar
  26. F. Locatelli, B. Canaud, F. Giacardy, A. Martin-Malo, N. Baker, and J. Wilson, “Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo),” Nephrology Dialysis Transplantation, vol. 18, pp. 362–369, 2003. View at Google Scholar
  27. T. Uzu, T. Hatta, N. Deji et al., “Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A1c,” Therapeutic Apheresis and Dialysis, vol. 13, no. 2, pp. 89–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Iida, H. Ishida, T. Tokumoto et al., “New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT,” International Urology and Nephrology, vol. 42, no. 4, pp. 935–945, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. W. G. J. Smith, M. Holden, M. Benton, and B. Brown, “Glycosylated and carbamylated haemoglobin in uraemia,” Nephrology Dialysis Transplantation, vol. 4, no. 2, pp. 96–100, 1989. View at Google Scholar · View at Scopus
  30. K. Kalantar-Zadeh, J. D. Kopple, D. L. Regidor et al., “A1C and survival in maintenance hemodialysis patients,” Diabetes Care, vol. 30, no. 5, pp. 1049–1055, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Ricks, M. Z. Molnar, C. P. Kovesdy et al., “Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study,” Diabetes, vol. 61, no. 3, pp. 708–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Abdul-Ghani, M. P. Stern, V. Lyssenko, T. Tuomi, L. Groop, and R. A. DeFronzo, “Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose,” Diabetes Care, vol. 33, no. 3, pp. 557–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Inoue, M. Matsumoto, and Y. Kobayashi, “The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers,” Diabetes Research and Clinical Practice, vol. 77, no. 3, pp. 451–458, 2007. View at Publisher · View at Google Scholar · View at Scopus